Guardant Health, Inc. provided revenue guidance for the year 2022. The company continues to expect full year 2022 revenue to be in the range of $460 million to $470 million, representing 23% to 26% growth over full year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.07 USD | -3.60% | -11.99% | -40.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.59% | 2.03B | |
-17.60% | 11.52B | |
+39.11% | 3.27B | |
-20.67% | 2.02B | |
-29.30% | 1.44B | |
+11.45% | 1.01B | |
-6.33% | 719M | |
-30.75% | 418M | |
-51.02% | 339M | |
-2.58% | 284M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Provides Revenue Guidance for the Year 2022